Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin oral gel for oral mucositis in head and neck cancer
NCT02630004Phase 2Completed
- Sponsor
- Spherium Biomed
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mucomel in oral mucositis (OM), sponsored by Spherium Biomed. Started Nov 2015; status: completed.
02
Drugs
Mucomel
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT02630004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630004.